BRAIDWELL LP — 13F Holdings & Portfolio
CIK 1920938 · latest 13F-HR filed 2026-08-14
BRAIDWELL LP manages $2.70B in 13F-reported U.S. long-equity assets across 86 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are CAI (5.44%), HNGE (4.08%), GKOS (3.06%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 24 new positions and exited 26; 30 existing positions rose in reported value and 21 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-08-14
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
Portfolio map
Q2 26Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.
Sector mix
% of 13F valueSectors from each company's SIC code; funds and ETFs grouped separately.
Biggest buys and sells
Q1 26 → Q2 26Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.
13F assets and positions
4 quartersTotal reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.
Top positions over time
reported valueThe eight largest current positions, valued at each quarter end.
Concentration
top 10 = 31.6%Cumulative share of the portfolio held in the largest N positions.
As of the firm’s regulatory filing dated Sep 22, 2026.
2ND FLOOR
STAMFORD, CT 06902
| Name | Title / Status | Ownership | Type |
|---|---|---|---|
| BRAIDWELL HOLDINGS LP Control | LIMITED PARTNER since Aug 2021 | 75% or more | Domestic Entity |
| BRAIDWELL MANAGEMENT LLC Control | GENERAL PARTNER since Aug 2021 | Less than 5% | Domestic Entity |
| KARNAL, ALEXANDER, THOMAS Control | CO-FOUNDER/CIO since Aug 2021 | Less than 5% | Individual |
| KREITER, BRIAN, JAMES Control | CO-FOUNDER/CEO since Aug 2021 | Less than 5% | Individual |
| Joseph, Ken, C | CHIEF COMPLIANCE OFFICER since Jan 2025 | Less than 5% | Individual |
| BRAIDWELL MANAGEMENT LLC Control Indirect owner via BRAIDWELL HOLDINGS LP | GENERAL PARTNER since Jan 2021 | General partner, trustee or manager | Domestic Entity |
| KARNAL, ALEXANDER, THOMAS Control Indirect owner via BRAIDWELL MANAGEMENT LLC | MANAGING MEMBER since Jan 2021 | 50–75% | Individual |
| KARNAL, ALEXANDER, THOMAS Control Indirect owner via BRAIDWELL HOLDINGS LP | LIMITED PARTNER since Jan 2021 | 50–75% | Individual |
| KREITER, BRIAN, JAMES Control Indirect owner via BRAIDWELL MANAGEMENT LLC | MANAGING MEMBER since Jan 2021 | 25–50% | Individual |
| KREITER, BRIAN, JAMES Control Indirect owner via BRAIDWELL HOLDINGS LP | LIMITED PARTNER since Jan 2021 | 25–50% | Individual |
Ownership & leadership changes · 1 filing with changes since Dec 1, 2021
From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.
- No longer listedMITAL, MANISH, KUMAR · CHIEF OPERATING OFFICER/GENERAL COUNSEL/CHIEF COMPLIANCE OFFICER · Less than 5% · control person · listed since Aug 2021
- AddedJoseph, Ken, C · CHIEF COMPLIANCE OFFICER · Less than 5%
- ListedBRAIDWELL HOLDINGS LP · LIMITED PARTNER · 75% or more · control person
- ListedBRAIDWELL MANAGEMENT LLC · GENERAL PARTNER · Less than 5% · control person
- ListedBRAIDWELL MANAGEMENT LLC · GENERAL PARTNER · General partner, trustee or manager · indirect via BRAIDWELL HOLDINGS LP · control person
- ListedKARNAL, ALEXANDER, THOMAS · CO-FOUNDER/CIO · Less than 5% · control person
- ListedKARNAL, ALEXANDER, THOMAS · MANAGING MEMBER · 50–75% · indirect via BRAIDWELL MANAGEMENT LLC · control person
- ListedKARNAL, ALEXANDER, THOMAS · LIMITED PARTNER · 50–75% · indirect via BRAIDWELL HOLDINGS LP · control person
- ListedKREITER, BRIAN, JAMES · CO-FOUNDER/CEO · Less than 5% · control person
- ListedKREITER, BRIAN, JAMES · MANAGING MEMBER · 25–50% · indirect via BRAIDWELL MANAGEMENT LLC · control person
- ListedKREITER, BRIAN, JAMES · LIMITED PARTNER · 25–50% · indirect via BRAIDWELL HOLDINGS LP · control person
- ListedMITAL, MANISH, KUMAR · CHIEF OPERATING OFFICER/GENERAL COUNSEL/CHIEF COMPLIANCE OFFICER · Less than 5% · control person
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- HINGE HEALTH INC$54.3M +96.8%
- ALPHATEC HLDGS INC$32.9M +139.0%
- SPYRE THERAPEUTICS INC$31.0M +65.9%
- NEOGENOMICS INC$30.1M +72.2%
- CLIMB BIO INC$26.0M +248.1%
Top Trims
- REPLIGEN CORP-$82.2M -83.3%
- NEOGENOMICS INC-$75.0M -81.6%
- ARGENX SE-$45.6M -73.5%
- NEUROCRINE BIOSCIENCES INC-$29.3M -34.1%
- CELLDEX THERAPEUTICS INC NEW-$26.8M -62.2%
New Positions
- HUMANA INC$45.5M
- MAZE THERAPEUTICS INC$34.0M
- AVALO THERAPEUTICS INC$30.1M
- ALAMAR BIOSCIENCES INC$29.4M
- ORUKA THERAPEUTICS INC$26.5M
Exited Positions
- GUARDANT HEALTH INC$102.6M
- CENTESSA PHARMACEUTICALS PLC$78.9M
- NUVALENT INC$71.8M
- CG ONCOLOGY INC$66.7M
- APOGEE THERAPEUTICS INC$40.3M
BRAIDWELL LP Holdings (2026-06-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | CARIS LIFE SCIENCES INC | CAI | 142152107 | $147.1M | 5.44% | 8,256,032 | SH |
| 2 | HINGE HEALTH INC | HNGE | 433313103 | $110.4M | 4.08% | 1,330,127 | SH |
| 3 | GLAUKOS CORP | GKOS | 377322102 | $82.7M | 3.06% | 591,927 | SH |
| 4 | EDGEWISE THERAPEUTICS INC | EWTX | 28036F105 | $81.1M | 3.00% | 1,996,965 | SH |
| 5 | SPYRE THERAPEUTICS INC | SYRE | 00773J202 | $78.1M | 2.89% | 879,467 | SH |
| 6 | IRHYTHM HOLDINGS INC | IRTC | 450056106 | $77.8M | 2.88% | 654,262 | SH |
| 7 | NEOGENOMICS INC | NEO | 64049M209 | $71.8M | 2.65% | 4,918,202 | SH |
| 8 | KODIAK SCIENCES INC | KOD | 50015M109 | $69.6M | 2.58% | 1,787,318 | SH |
| 9 | XENON PHARMACEUTICALS INC | XENE | 98420N105 | $68.3M | 2.53% | 1,131,452 | SH |
| 10 | ALPHATEC HLDGS INC | ATEC | 02081GAD4 | $66.2M | 2.45% | 69,121,000 | PRN |
| 11 | MONTE ROSA THERAPEUTICS INC | GLUE | 61225M102 | $59.3M | 2.19% | 2,451,562 | SH |
| 12 | DIANTHUS THERAPEUTICS INC | DNTH | 252828108 | $58.0M | 2.14% | 594,562 | SH |
| 13 | NEUROCRINE BIOSCIENCES INC | NBIX | 64125C109 | $56.7M | 2.10% | 336,171 | SH |
| 14 | ALPHATEC HLDGS INC | ATEC | 02081G201 | $56.5M | 2.09% | 6,531,439 | SH |
| 15 | GENERATE BIOMEDICINES INC | GENB | 370920100 | $55.4M | 2.05% | 3,283,844 | SH |
| 16 | MARAVAI LIFESCIENCES HLDGS I | MRVI | 56600D107 | $54.3M | 2.01% | 8,702,921 | SH |
| 17 | KRYSTAL BIOTECH INC | KRYS | 501147102 | $47.9M | 1.77% | 128,975 | SH |
| 18 | HUMANA INC | HUM | 444859102 | $45.5M | 1.68% | 114,500 | SH |
| 19 | THERMO FISHER SCIENTIFIC INC | TMO | 883556102 | $44.8M | 1.66% | 89,395 | SH |
| 20 | KYMERA THERAPEUTICS INC | KYMR | 501575104 | $43.4M | 1.60% | 378,163 | SH |
| 21 | RHYTHM PHARMACEUTICALS INC | RYTM | 76243J105 | $42.3M | 1.57% | 381,128 | SH |
| 22 | DAMORA THERAPEUTICS INC | DMRA | 36322Q206 | $42.1M | 1.56% | 1,620,377 | SH |
| 23 | ACADIA PHARMACEUTICALS INC | ACAD | 004225108 | $41.7M | 1.54% | 1,646,399 | SH |
| 24 | BRIGHTSPRING HEALTH SVCS INC | BTSG | 10950A106 | $41.6M | 1.54% | 596,753 | SH |
| 25 | TRANSMEDICS GROUP INC | TMDX | 89377M109 | $40.5M | 1.50% | 609,715 | SH |
| 26 | MBX BIOSCIENCES INC | MBX | 55287L101 | $39.2M | 1.45% | 710,880 | SH |
| 27 | CLIMB BIO INC | CLYM | 28658R106 | $36.5M | 1.35% | 2,797,375 | SH |
| 28 | CAREDX INC | CDNA | 14167L103 | $34.8M | 1.29% | 1,220,602 | SH |
| 29 | MAZE THERAPEUTICS INC | MAZE | 578784100 | $34.0M | 1.26% | 1,140,040 | SH |
| 30 | BRIGHT MINDS BIOSCIENCES INC | DRUG | 10919W405 | $34.0M | 1.26% | 483,822 | SH |
| 31 | ACADIA HEALTHCARE COMPANY IN | ACHC | 00404A109 | $33.7M | 1.25% | 1,141,477 | SH |
| 32 | NEKTAR THERAPEUTICS | NKTR | 640268306 | $33.1M | 1.22% | 473,617 | SH |
| 33 | CORVUS PHARMACEUTICALS INC | CRVS | 221015100 | $31.8M | 1.18% | 2,126,298 | SH |
| 34 | NURIX THERAPEUTICS INC | NRIX | 67080M103 | $31.2M | 1.15% | 1,286,769 | SH |
| 35 | INSPIRE MED SYS INC | INSP | 457730109 | $30.2M | 1.12% | 677,570 | SH |
| 36 | AVALO THERAPEUTICS INC | AVTX | 05338F306 | $30.1M | 1.11% | 1,629,182 | SH |
| 37 | ALAMAR BIOSCIENCES INC | ALMR | 010911105 | $29.4M | 1.09% | 1,083,983 | SH |
| 38 | DANAHER CORP DEL | DHR | 235851102 | $28.7M | 1.06% | 150,627 | SH |
| 39 | INTUITIVE SURGICAL INC | ISRG | 46120E602 | $27.9M | 1.03% | 70,137 | SH |
| 40 | ORUKA THERAPEUTICS INC | ORKA | 687604108 | $26.5M | 0.98% | 278,164 | SH |
| 41 | AVALYN PHARMACEUTICALS INC | AVLN | 05348Y105 | $26.4M | 0.98% | 801,395 | SH |
| 42 | AVEANNA HEALTHCARE HLDGS INC | AVAH | 05356F105 | $26.3M | 0.97% | 3,065,106 | SH |
| 43 | BIOAGE LABS INC | BIOA | 09077V100 | $25.3M | 0.94% | 1,033,129 | SH |
| 44 | BOSTON SCIENTIFIC CORP | BSX | 101137107 | $25.1M | 0.93% | 587,567 | SH |
| 45 | VERA THERAPEUTICS INC | VERA | 92337R101 | $24.2M | 0.90% | 564,724 | SH |
| 46 | REPLIGEN CORP | RGEN | 759916109 | $24.2M | 0.89% | 177,100 | SH |
| 47 | ZURA BIO LTD | ZURA | G9TY5A101 | $23.5M | 0.87% | 3,980,295 | SH |
| 48 | GUARDANT HEALTH INC | GH | 40131M109 | $22.2M | 0.82% | 147,850 | SH |
| 49 | EVOLUS INC | EOLS | 30052C107 | $21.9M | 0.81% | 3,155,209 | SH |
| 50 | NATERA INC | NTRA | 632307104 | $21.6M | 0.80% | 79,500 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $2.70B | 86 | 0001420506-26-001823 |
| 2026-03-31 | 2026-05-15 | $3.00B | 88 | 0001420506-26-001145 |
| 2025-12-31 | 2026-02-17 | $3.13B | 73 | 0001420506-26-000586 |
| 2025-09-30 | 2025-11-14 | $3.37B | 73 | 0001420506-25-003410 |
2ND FLOOR
STAMFORD, CT 06902